ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
11.34
+0.26 (2.35%)
At close: Jul 24, 2025, 2:57 PM CST
ChemPartner PharmaTech Revenue
ChemPartner PharmaTech had revenue of 261.26M CNY in the quarter ending March 31, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to 996.87M, down -9.73% year-over-year. In the year 2024, ChemPartner PharmaTech had annual revenue of 970.20M, down -14.77%.
Revenue (ttm)
996.87M
Revenue Growth
-9.73%
P/S Ratio
5.68
Revenue / Employee
549.54K
Employees
1,814
Market Cap
5.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 970.20M | -168.16M | -14.77% |
Dec 31, 2023 | 1.14B | -188.22M | -14.19% |
Jan 1, 2023 | 1.33B | -364.09M | -21.54% |
Jan 1, 2022 | 1.69B | 209.09M | 14.11% |
Dec 31, 2020 | 1.48B | 153.77M | 11.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |